SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-19-008087
Filing Date
2019-08-13
Accepted
2019-08-13 17:27:07
Documents
2
Period of Report
2019-07-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A f8-ka.htm 8-K/A 56963
2 EX-10.1 ex-10d1.htm EX-10.1 25353
  Complete submission text file 0001558370-19-008087.txt   83437
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37809 | Film No.: 191021860
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1